Results 111 to 120 of about 28,367 (198)

Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]

BMJ Open Respir Res
Chavda A, Gilchrist M, Capstick T, Chen C, Kon OM.   +4 more
europepmc   +1 more source

Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysis. [PDF]

BMC Infect Dis
Guzman KJ, Wolf A, Perumal R, Lu X, Boodhram R, Seepamore B, Reis K, Amico KR, Friedland G, Zelnick JR, Daftary A, Cummings M, Padayatchi N, Naidoo K, O'Donnell M.   +14 more
europepmc   +1 more source

Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in California. [PDF]

Open Forum Infect Dis
Katrak SS, Wang RC, Keh CE, Nabity SA, Okada RC, Raftery A, Wendorf KA, Agraz-Lara R, Chakrabarty M, Chevinsky JR, Chitnis AS, Dasgupta-Tsinikas S, Goozé L, Kadakia A, Kaiser C, Louie JK, Morgan J, Nguyen TD, Percak J, Polesky AH, Radner A, Sahni H, Sreenivasan M, Sherrick R, Soukup JD, Waterman C, Yeturu P, Yu S, Barry PM.   +28 more
europepmc   +1 more source

High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the Philippines. [PDF]

IJTLD Open
Flores I, Tujan MAA, Basilio R, Dizon TJR, Lim DR, Reyes LT, Reyes RVAG, Rojas S, Valencia AK, Capin JB, Mirtskhulava V, Palparan AG, Cabalitan C, Carpin PJ, Malbacias C, Lee JS, Gebhard A, Quelapio M, Timm J.   +18 more
europepmc   +1 more source

Epidemiological Characteristics and Treatment Outcomes of Drug-Resistant Tuberculosis in Limpopo Province, South Africa (2020-2024). [PDF]

Trop Med Infect Dis
Rukasha I, Kaapu KG.
europepmc   +1 more source

Rising bedaquiline resistance: exploring potential causes and next steps. [PDF]

Eur Respir J
Schildkraut JA, Flood D, Sloan DJ, Heinrich N, Fox S, Lange C, Wells C, Tiberi S.   +7 more
europepmc   +1 more source

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa. [PDF]

Clin Infect Dis
Loveday M, Clarence E, Hlangu S, Singh N, Chotoo S, Brust JCM, Waitt C, Court R, Furin J.   +8 more
europepmc   +1 more source

Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study. [PDF]

Lancet Microbe
Steyn J, Williams J, Naufal F, Limberis J, Grobbelaar M, Ismail N, Ghebrekristos Y, Opperman CJ, Nalyvayko A, Singh S, Colman RE, Rodwell TC, Theron G, Warren RM, Metcalfe JZ.   +14 more
europepmc   +1 more source

Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]

BMJ Med
Mahmood A, Ashfaq MB, Drain C, Melby E, Hunter M, Shaw TD.   +5 more
europepmc   +1 more source

Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. [PDF]

Front Microbiol
Malope P, Lekalakala-Mokaba MR, Ngcamu DC, Said H, Rukasha I, Omar SV.   +5 more
europepmc   +1 more source